Table 1.

Patients' demographics, comorbidities and maximal respiratory support required during hospital attendance (n=526)

Patients, n (%)
Sex
Women221 (42.0)
Men305 (58.0)
Ethnicity
Asian or Asian British54 (10.3)
Black, Black British, Caribbean or African85 (16.2)
Mixed or multiple ethnic groups11 (2.1)
White167 (31.7)
Any other ethnic group116 (22.1)
Not specified93 (17.7)
Pre-existing comorbidities
Hypertension225 (42.8)
Diabetes mellitus152 (28.9)
Asthma77 (14.6)
Ischaemic heart disease43 (8.2)
Obesity41 (7.8)
Chronic kidney disease25 (4.8)
Chronic obstructive pulmonary disease23 (4.4)
Heart failure6 (1.1)
Interstitial lung disease3 (0.6)
Maximal respiratory support required during hospital attendance or inpatient stay
None148 (28.1)
Supplementary oxygen with peak FiO2 <60%238 (45.2)
Supplementary oxygen with peak FiO2 ≥60% but not requiring CPAP, HFNO/Optiflow, NIV or mechanical ventilation65 (12.4)
CPAP6 (1.1)
HFNO/Optiflow3 (0.6)
NIV2 (0.4)
Mechanical ventilation64 (12.2)
  • CPAP = continuous positive airway pressure; FiO2 = fraction of inspired oxygen; HFNO = high-flow nasal oxygen; NIV = non-invasive ventilation.